Wearable devices can transform heart failure management by enabling continuous monitoring and early detection of decompensation, despite challenges in data integration and regulatory approval.
What is the role and potential of wearable technology in heart failure management?
Wearable devices offer promising capabilities for continuous monitoring and early intervention in heart failure, though widespread adoption requires overcoming integration and regulatory hurdles.
BACKGROUND: Heart failure (HF) management increasingly relies on innovative solutions to enhance monitoring and care. Wearable devices, originally popularized for fitness tracking, show promise in clinical decision-making for HF. This study explores the application and potential for the broader integration of wearable technology in HF management, emphasizing remote monitoring and personalized care. METHODS: A comprehensive literature review was performed to assess the role of wearables in HF management, focusing on functionalities like vital sign tracking, patient engagement, and clinical decision support. Clinical outcomes and barriers to adopting wearable technology in HF care were critically analyzed. RESULTS: Wearable devices increasingly track physiological parameters relevant to HF, such as heart rate, physical activity, and sleep. They can identify at-risk patients, promote lifestyle changes, facilitate early diagnosis, and accurately detect arrhythmias that lead to decompensation. Additionally, wearables may assess fluid status, identifying early signs of decompensation to prevent hospitalization and supporting therapeutic adjustments. They also enhance physical activity and optimize cardiac rehabilitation programs, improving patient outcomes. Both wearable and implanted cardiac devices enable continuous, non-invasive monitoring through small devices. However, challenges like data integration, regulatory approval, and reimbursement impede their widespread adoption. CONCLUSIONS: Wearable technology can transform HF management through continuous monitoring and early interventions. Collaboration among involved parties is essential to overcome integration challenges and validate most of these devices in clinical practice.
Gregório et al. (Fri,) conducted a review in Heart failure. Wearable devices was evaluated. Wearable devices can transform heart failure management by enabling continuous monitoring and early detection of decompensation, despite challenges in data integration and regulatory approval.